Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 12-2013 | 09-2013 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 676 | 1,552 | N/A | N/A | N/A |
| TOTAL | $736 | $1,552 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| Intangibles | 5 | 5 | 0 | 0 | 0 |
| TOTAL | $5 | $5 | $N/A | $N/A | $N/A |
| Total Assets | $742 | $1,558 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 559 | 106 | 0 | 0 | 0 |
| Accrued Expenses | 8 | 86 | N/A | N/A | N/A |
| Other current liabilities | 809 | 1,507 | N/A | N/A | N/A |
| TOTAL | $1,377 | $2,299 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,377 | $2,299 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93 | N/A | N/A | N/A | N/A |
| Common Shares | 34 | 30 | N/A | N/A | N/A |
| Retained earnings | -9,041 | -6,138 | N/A | N/A | N/A |
| TOTAL | $-635 | $-742 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $742 | $1,558 | $0 | $0 | $0 |